Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
SurModics Inc (SRDX)
:SRDX
SRDX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$25.17 - $42.44
Previous CloseN/A
Volume44.36K
Average Volume (3M)329.24K
Market Cap
$487.35M
Enterprise Value$566.43M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.24
Next Earnings
Apr 30, 2025EPS Estimate
-0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.01
Shares Outstanding14,295,998
10 Day Avg. Volume264,549
30 Day Avg. Volume329,237
Standard Deviation0.16
R-Squared0.16
Alpha-0.00663
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.88
Price to Cash Flow (P/CF)-15.40
P/FCF Ratio0.00
Enterprise Value/Market Cap1.16
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit6.09
Enterprise Value/Ebitda582.75
Forecast
1Y Price Target
$43.00Price Target Upside25.33% Upside
Rating ConsensusHold
Number of Analyst Covering3
---
SurModics News
PremiumCompany Announcements
Surmodics Reports Q1 Loss and Strategic Moves
PremiumCompany Announcements
Surmodics Inc. Reports Q4 and FY 2024 Results
---
Bulls Say, Bears Say
Bulls Say
Acquisition PremiumSurmodics shareholders will receive $43.00/share in cash, a 22.5% premium to the closing price on May 28, 2024.
Financial PerformanceRoyalty and licensing revenue exceeded expectations, achieving $10.6 million compared to the estimated $9.7 million.
Bears Say
Acquisition UncertaintyRecent trading activity in SRDX shares indicates significant skepticism about the acquisition deal with GTCR being completed.
---
Ownership Overview
3.32% Insiders
16.48% Mutual Funds
29.64% Other Institutional Investors
37.76% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SRDX FAQ
What was SurModics Inc’s price range in the past 12 months?
SurModics Inc lowest stock price was $25.17 and its highest was $42.44 in the past 12 months.
What is SurModics Inc’s market cap?
SurModics Inc’s market cap is $487.35M.
When is SurModics Inc’s upcoming earnings report date?
SurModics Inc’s upcoming earnings report date is Apr 30, 2025 which is in 67 days.
How were SurModics Inc’s earnings last quarter?
SurModics Inc released its earnings results on Jan 30, 2025. The company reported -$0.04 earnings per share for the quarter, beating the consensus estimate of -$0.117 by $0.077.
Is SurModics Inc overvalued?
According to Wall Street analysts SurModics Inc’s price is currently Undervalued.
Does SurModics Inc pay dividends?
SurModics Inc does not currently pay dividends.
What is SurModics Inc’s EPS estimate?
SurModics Inc’s EPS estimate is -0.09.
How many shares outstanding does SurModics Inc have?
SurModics Inc has 14,295,998 shares outstanding.
What happened to SurModics Inc’s price movement after its last earnings report?
SurModics Inc reported an EPS of -$0.04 in its last earnings report, beating expectations of -$0.117. Following the earnings report the stock price went down -0.838%.
Which hedge fund is a major shareholder of SurModics Inc?
Currently, no hedge funds are holding shares in SRDX
---
SurModics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$43.00 (25.33% Upside)
$43.00 (25.33% Upside)
Blogger Sentiment
Bullish
SRDX Sentiment 70%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $276.4K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
8.90%
12-Months-Change
Fundamentals
Return on Equity
-12.32%
Trailing 12-Months
Asset Growth
-9.15%
Trailing 12-Months
Company Description
SurModics Inc
SurModics, Inc. engages in the provision of medical device and in vitro diagnostic technologies to the healthcare industry. It operates through the Medical Device and In Vitro Diagnostics segments. The Medical Device segment designs, develops, and manufactures interventional medical devices, surface modification coating technologies, as well as drug-delivery coating technologies. The In Vitro Diagnostics segment consists of component products and technologies for diagnostic test kits and biomedical research applications. The company was founded in June 1979 and is headquartered in Eden Prairie, MN.
---
SRDX Stock 12 Month Forecast
Average Price Target
$43.00
▲(25.33% Upside)
Technical Analysis
---